Annual Non Current Assets
$62.58 M
-$1.09 M-1.71%
December 31, 2023
Summary
- As of February 7, 2025, LCTX annual long term assets is $62.58 million, with the most recent change of -$1.09 million (-1.71%) on December 31, 2023.
- During the last 3 years, LCTX annual non current assets has fallen by -$1.37 million (-2.15%).
- LCTX annual non current assets is now -52.09% below its all-time high of $130.62 million, reached on December 31, 2017.
Performance
LCTX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$62.19 M
-$219.00 K-0.35%
September 30, 2024
Summary
- As of February 7, 2025, LCTX quarterly long term assets is $62.19 million, with the most recent change of -$219.00 thousand (-0.35%) on September 30, 2024.
- Over the past year, LCTX quarterly non current assets has dropped by -$479.00 thousand (-0.76%).
- LCTX quarterly non current assets is now -68.69% below its all-time high of $198.64 million, reached on September 30, 2017.
Performance
LCTX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
LCTX Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.7% | -0.8% |
| 3 y3 years | -2.1% | -0.7% |
| 5 y5 years | -4.2% | -1.8% |
LCTX Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.7% | at low | -2.3% | +0.5% |
| 5 y | 5-year | -7.9% | at low | -8.5% | +0.5% |
| alltime | all time | -52.1% | -100.0% | -68.7% | -100.0% |
Lineage Cell Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $62.19 M(-0.4%) |
| Jun 2024 | - | $62.41 M(-0.6%) |
| Mar 2024 | - | $62.77 M(+0.3%) |
| Dec 2023 | $38.44 M(-35.9%) | $62.58 M(-0.1%) |
| Sep 2023 | - | $62.67 M(-0.8%) |
| Jun 2023 | - | $63.20 M(-0.6%) |
| Mar 2023 | - | $63.55 M(-0.2%) |
| Dec 2022 | $60.00 M(-46.2%) | $63.66 M(+1.6%) |
| Sep 2022 | - | $62.64 M(+1.2%) |
| Jun 2022 | - | $61.90 M(-1.2%) |
| Mar 2022 | - | $62.65 M(-0.6%) |
| Dec 2021 | $111.55 M(+153.5%) | $63.00 M(+0.2%) |
| Sep 2021 | - | $62.87 M(-0.5%) |
| Jun 2021 | - | $63.18 M(-0.2%) |
| Mar 2021 | - | $63.31 M(-1.0%) |
| Dec 2020 | $44.00 M(-23.5%) | $63.95 M(+0.9%) |
| Sep 2020 | - | $63.35 M(-3.8%) |
| Jun 2020 | - | $65.88 M(-1.1%) |
| Mar 2020 | - | $66.60 M(-2.0%) |
| Dec 2019 | $57.52 M(+58.2%) | $67.96 M(-4.8%) |
| Sep 2019 | - | $71.39 M(-45.6%) |
| Jun 2019 | - | $131.23 M(-14.3%) |
| Mar 2019 | - | $153.06 M(+134.4%) |
| Dec 2018 | $36.36 M(-14.7%) | $65.30 M(-53.1%) |
| Sep 2018 | - | $139.17 M(+79.0%) |
| Jun 2018 | - | $77.76 M(+4.7%) |
| Mar 2018 | - | $74.27 M(-43.1%) |
| Dec 2017 | $42.62 M(+66.2%) | $130.62 M(-34.2%) |
| Sep 2017 | - | $198.64 M(+18.4%) |
| Jun 2017 | - | $167.83 M(-4.6%) |
| Mar 2017 | - | $175.96 M(+50.5%) |
| Dec 2016 | $25.65 M(-45.7%) | $116.92 M(+4.0%) |
| Sep 2016 | - | $112.42 M(+53.4%) |
| Jun 2016 | - | $73.28 M(+55.2%) |
| Mar 2016 | - | $47.21 M(-0.5%) |
| Dec 2015 | $47.24 M(+45.8%) | $47.42 M(+11.6%) |
| Sep 2015 | - | $42.49 M(-0.3%) |
| Jun 2015 | - | $42.61 M(+3.5%) |
| Mar 2015 | - | $41.16 M(-3.1%) |
| Dec 2014 | $32.41 M(+307.6%) | $42.50 M(-7.0%) |
| Sep 2014 | - | $45.72 M(-3.4%) |
| Jun 2014 | - | $47.34 M(-2.8%) |
| Mar 2014 | - | $48.70 M(-2.2%) |
| Dec 2013 | $7.95 M(+10.7%) | $49.78 M(+124.5%) |
| Sep 2013 | - | $22.17 M(+1.9%) |
| Jun 2013 | - | $21.76 M(-2.5%) |
| Mar 2013 | - | $22.33 M(-1.1%) |
| Dec 2012 | $7.18 M(-71.2%) | $22.57 M(-2.4%) |
| Sep 2012 | - | $23.12 M(-2.7%) |
| Jun 2012 | - | $23.78 M(+16.9%) |
| Mar 2012 | - | $20.33 M(-2.6%) |
| Dec 2011 | $24.96 M(-29.8%) | $20.87 M(-6.5%) |
| Sep 2011 | - | $22.32 M(-7.1%) |
| Jun 2011 | - | $24.04 M(-1.0%) |
| Mar 2011 | - | $24.28 M(+37.1%) |
| Dec 2010 | $35.57 M(+187.7%) | $17.70 M(+21.4%) |
| Sep 2010 | - | $14.58 M(-3.8%) |
| Jun 2010 | - | $15.16 M(+1064.1%) |
| Mar 2010 | - | $1.30 M(+22.1%) |
| Dec 2009 | $12.37 M(>+9900.0%) | $1.07 M(-0.4%) |
| Sep 2009 | - | $1.07 M(+2.5%) |
| Jun 2009 | - | $1.05 M(-0.1%) |
| Mar 2009 | - | $1.05 M(+12.9%) |
| Dec 2008 | $108.90 K | $926.60 K(-0.6%) |
| Sep 2008 | - | $931.80 K(+230.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2008 | - | $282.30 K(+740.2%) |
| Mar 2008 | - | $33.60 K(+0.3%) |
| Dec 2007 | $141.60 K(-77.1%) | $33.50 K(+13.6%) |
| Sep 2007 | - | $29.50 K(-3.0%) |
| Jun 2007 | - | $30.40 K(-4.4%) |
| Mar 2007 | - | $31.80 K(0.0%) |
| Dec 2006 | $618.70 K(-68.0%) | $31.80 K(+7.1%) |
| Sep 2006 | - | $29.70 K(-2.3%) |
| Jun 2006 | - | $30.40 K(+18.3%) |
| Mar 2006 | - | $25.70 K(-5.5%) |
| Dec 2005 | $1.93 M(+29.4%) | $27.20 K(-3.5%) |
| Sep 2005 | - | $28.20 K(-3.1%) |
| Jun 2005 | - | $29.10 K(+203.1%) |
| Mar 2005 | - | $9600.00(-66.4%) |
| Dec 2004 | $1.49 M(+48.3%) | $28.60 K(-16.6%) |
| Sep 2004 | - | $34.30 K(-19.7%) |
| Jun 2004 | - | $42.70 K(-19.7%) |
| Mar 2004 | - | $53.20 K(-17.5%) |
| Dec 2003 | $1.01 M(-27.1%) | $64.50 K(-19.8%) |
| Sep 2003 | - | $80.40 K(-7.2%) |
| Jun 2003 | - | $86.60 K(-12.8%) |
| Mar 2003 | - | $99.30 K(-12.9%) |
| Dec 2002 | $1.38 M(-21.6%) | $114.00 K(-12.2%) |
| Sep 2002 | - | $129.90 K(-10.8%) |
| Jun 2002 | - | $145.70 K(-10.2%) |
| Mar 2002 | - | $162.30 K(-9.4%) |
| Dec 2001 | $1.76 M(+22.3%) | $179.20 K(-8.1%) |
| Sep 2001 | - | $194.90 K(-5.2%) |
| Jun 2001 | - | $205.60 K(-5.9%) |
| Mar 2001 | - | $218.50 K(-7.6%) |
| Dec 2000 | $1.44 M(-73.3%) | $236.50 K(-7.5%) |
| Sep 2000 | - | $255.80 K(-5.5%) |
| Jun 2000 | - | $270.60 K(+1.0%) |
| Mar 2000 | - | $267.80 K(-3.9%) |
| Dec 1999 | $5.40 M(+107.7%) | $278.60 K(-7.1%) |
| Sep 1999 | - | $300.00 K(0.0%) |
| Jun 1999 | - | $300.00 K(+50.0%) |
| Mar 1999 | - | $200.00 K(-33.3%) |
| Dec 1998 | $2.60 M(-39.5%) | - |
| Sep 1998 | - | $300.00 K(0.0%) |
| Jun 1998 | - | $300.00 K(+50.0%) |
| Jun 1998 | $4.30 M(-47.6%) | - |
| Mar 1998 | - | $200.00 K(+100.0%) |
| Dec 1997 | - | $100.00 K(-50.0%) |
| Sep 1997 | - | $200.00 K(+100.0%) |
| Jun 1997 | $8.20 M(+182.8%) | $100.00 K(0.0%) |
| Mar 1997 | - | $100.00 K(0.0%) |
| Dec 1996 | - | $100.00 K(0.0%) |
| Sep 1996 | - | $100.00 K(0.0%) |
| Jun 1996 | $2.90 M(-17.1%) | $100.00 K(0.0%) |
| Sep 1995 | - | $100.00 K(0.0%) |
| Jun 1995 | $3.50 M(-39.7%) | $100.00 K(0.0%) |
| Mar 1995 | - | $100.00 K(-50.0%) |
| Dec 1994 | - | $200.00 K(+100.0%) |
| Sep 1994 | - | $100.00 K(0.0%) |
| Jun 1994 | $5.80 M(+65.7%) | $100.00 K(>+9900.0%) |
| Mar 1994 | - | $0.00(-100.0%) |
| Dec 1993 | - | $100.00 K(>+9900.0%) |
| Sep 1993 | - | $0.00(0.0%) |
| Jun 1993 | $3.50 M(-27.1%) | $0.00(-100.0%) |
| Mar 1993 | - | $100.00 K(>+9900.0%) |
| Dec 1992 | - | $0.00(-100.0%) |
| Sep 1992 | - | $100.00 K(>+9900.0%) |
| Jun 1992 | $4.80 M | $0.00(0.0%) |
| Mar 1992 | - | $0.00 |
FAQ
- What is Lineage Cell Therapeutics annual long term assets?
- What is the all time high annual non current assets for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics annual non current assets year-on-year change?
- What is Lineage Cell Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics quarterly non current assets year-on-year change?
What is Lineage Cell Therapeutics annual long term assets?
The current annual non current assets of LCTX is $62.58 M
What is the all time high annual non current assets for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high annual long term assets is $130.62 M
What is Lineage Cell Therapeutics annual non current assets year-on-year change?
Over the past year, LCTX annual long term assets has changed by -$1.09 M (-1.71%)
What is Lineage Cell Therapeutics quarterly long term assets?
The current quarterly non current assets of LCTX is $62.19 M
What is the all time high quarterly non current assets for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high quarterly long term assets is $198.64 M
What is Lineage Cell Therapeutics quarterly non current assets year-on-year change?
Over the past year, LCTX quarterly long term assets has changed by -$479.00 K (-0.76%)